Lung Cancer Treatments and Mutations
This is a sourced subject-directory page. Its presence does not mean a factual answer has been researched, or that the subject is a proven knowledge gap.
Scope of this subject
This cluster of papers focuses on the advancements in lung cancer research, particularly in understanding EGFR and ALK mutations, targeted therapy, resistance mechanisms to tyrosine kinase inhibitors, clinical trials evaluating different treatment regimens, genomic profiling for personalized medicine, and the development of treatment guidelines based on molecular biomarkers. The research also explores the concept of oncogene addiction and its implications for targeted therapies.
OpenAlex generated this cluster description with an LLM. It describes research grouping, not verified findings.
Follow the subject hierarchy
Research vocabulary
non-small cell lung cancer; EGFR tyrosine kinase inhibitors; EGFR mutation; gefitinib; erlotinib; advanced non-small cell lung cancer; osimertinib; EGFR-mutant non-small cell lung cancer; T790M mutation; ALK inhibitors; anaplastic lymphoma kinase; acquired drug resistance; crizotinib; ALK rearrangement; afatinib; L858R mutation; pemetrexed; ALK-positive non-small cell lung cancer; exon 19 deletion; metastatic non-small cell lung cancer; EGFR tyrosine kinase inhibitor resistance; MET amplification; metastatic lung cancer; advanced lung cancer; EML4-ALK fusion
Current OpenAlex keyword associations; absence of a keyword does not establish absent knowledge.
Find the underlying research
OpenAlex topic record · Works associated with this topic
These external lists help locate papers. Assess the paper, date, method and limitations before using it as evidence. This service does not fetch submitted URLs.
Local answer status
No owner-reviewed answer has been published for this exact subject page. This is a gap in this collection; it does not establish that the answer is unavailable elsewhere.
Numeric address and provenance
Morton address: 36240181364139306 · morton4x16-v1
Coordinates: (4, 27, 2740, 10417). The address interleaves categorical identifier bits. Nearby addresses are not guaranteed to describe semantically similar subjects.
Structured subject record · Markdown · Source snapshots and licenses
What could you not find?
Submit the specific question you still need answered. This creates a private research request for owner review; it does not declare a scientific discovery or automatically generate an answer.